Business Wire - August 13, 2002
"Nepal has a population of about 25 million and represents a new country that WDI has entered to serve the medical needs of its people. Rapid screening of HIV and Hepatitis of local blood supplies, and their use in surveillance programs, is a high priority in the efforts to minimize the spread of these infectious diseases.
"Initial sales to the government of Nepal are relatively small at this time. However, we are proving that a small company, with innovative ideas and the ability to bring modern medical technology to meet the needs of emerging and lesser-developed countries, can do the job on a cost-efficient basis. While we presently cannot forecast sales of these tests, in general, infection rates of these diseases are rising on a worldwide endemic level.
"WDI is committed to bringing state-of-the-art medical technology to the emerging markets of the world to improve healthcare and education, especially concerning infectious diseases. We believe our Company can make a difference in providing high-quality, affordable diagnostic tests, which is a critical contribution to Nepal's identification, treatment and care strategy," commented Barry Peters, Chairman of World Diagnostics.
About World Diagnostics, Inc. and GLOBALeMED.com
WDI is an innovative leader providing a wide range of medical diagnostic and laboratory products worldwide, and offering the most comprehensive resource for most medical diagnostic tests and laboratory products on a global basis. WDI provides a network of conventional and dedicated distribution channels for accessing global international markets, and a simplified option, through its GLOBALeMED e-commerce platform, for purchasing medical laboratory and healthcare products online.
WDI's marketing platform of distributors and GLOBALeMED partners covers 85 countries, affording professional users easy and unlimited access to critical technical data and information, training aids and online customer support. It is among the most comprehensive resources available for most medical diagnostic tests and laboratory products, currently comprising about 1,000 WDI-branded and numerous other products sold through distributors and directly to medical professionals, hospitals, physician offices, clinical laboratories and retail drug stores.
WDI's GLOBALeMED website is the only multi-cultural, multi-lingual, medical information-based website of its kind, generating new business leads daily and convenient transactional options, either through conventional distribution or e-commerce options.
WDI's vision is to be the premier resource for supplying diagnostic tests and allied medical products for the $5 billion emerging nation global marketplace. WDI is aggressively expanding its business and brand name through its distribution network and its GLOBALeMED e-commerce platform, which can be accessed at either www.worlddiagnostics.com or www.globalemed.com. WDI's GLOBALeMED website delivers efficient access to modern medical technology on a cost-effective basis. WDI has built substantial inroads and assets in the form of licenses and registrations for its products in numerous countries, generating new customers and business leads daily that contribute to WDI's growing name recognition on a worldwide basis.
Except for historical matters contained herein, the matters discussed in this press release are forward-looking statements and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect the assumptions and involve risk and uncertainties, which may affect World Diagnostics, Inc.'s business and prospects and cause actual results to differ materially from these forward-looking statements.
SOURCE: World Diagnostics, Inc.
REPEATS: New York 212-752-9600 or 800-221-2462; Boston 617-236-4266 or
020813
BW020806
Copyright © 2002 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .